Inhibition of SUMO2/3 antagonizes isoflurane-induced cancer-promoting effect in hepatocellular carcinoma Hep3B cells

Surgery for patients with complicated liver cancer often results in a long exposure to anesthesia with an increase in side effects. Continued long-term exposure to isoflurane may promote liver cancer progression. Small ubiquitin-like modifier (SUMO) 2 and 3, also known as SUMO2/3, conjugates to subs...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peng, Xue, Na, Zhang, Chunyan, Shan, Shimin, Jiang, Zhongmin, Wu, Wenhan, Liu, Xiaozhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905670/
https://www.ncbi.nlm.nih.gov/pubmed/33732350
http://dx.doi.org/10.3892/ol.2021.12535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7905670/
https://www.ncbi.nlm.nih.gov/pubmed/33732350
http://dx.doi.org/10.3892/ol.2021.12535

Ejemplares similares